There was no difference in CXCR1 and CXCR2 expression in patients with different AAV diseases or between patients with MPO- or PR3- ANCA specificity (data not shown). This evidence concerns the gene MPO and anti-neutrophil cytoplasmic antibody-associated vasculitis.